Apart from any disturbance imposed by the alternative isoform itself, any changes in canonical Cd74 activity due to its putative association with the novel isoform could be envisioned to disturb the fine-tuned balance of immune surveillance mechanisms holding a tumor at bay. The gene discussed is CD74; the disease is neoplasm.